Table 2.
Measures by time point assessed and mode of administration
| Assessment goal | Measure/study procedure | Time point | Mode |
| Diagnostic and screening | Phone screen (to determine eligibility) | Pre-B | Interview |
| Screening, demographics, medical review | B | Self-report | |
| Structured Clinical Interview for DSM-V | B | Interview | |
| EEG | B | Clinician administered | |
| SUD | Timeline follow-back | B, W, PT1 PT2 | Interview |
| Alcohol Urge Questionnaire, Cocaine Urge Questionnaire or Opioid Urge Questionnaire | B, W, PT1, PT2 | Self-report | |
| PTSD | Clinician-Administered PTSD Scale | B, PT1, PT2 | Interview |
| PTSD Checklist for DSM-V | B, PT1, PT2 | Self-report | |
| The Life Events Checklist | B | Self-report | |
| Depression | Inventory of Depressive Symptomatology Self-Report | B, PT1, PT2 | Self-report |
| Affect | Positive and Negative Affect Schedule | B, PT1, PT2 | Self-report |
| Anxiety | State-Trait Anxiety Inventory | B, PT1, PT2 | Self-report |
| Quality of Life | Quality of Life Enjoyment and Satisfaction Questionnaire | B, PT1, PT2 | Self-report |
| Social and Occupational Functioning Assessment Scale | B, PT1, PT2 | Self-report | |
| Sleep | Pittsburgh Sleep Quality Index | B, W, PT1, PT2 | Self-report |
| General | Clinical Global Impressions–Severity (CGI-s) | B, PT1, PT2 | Interview |
| CGI–Improvement (CGI-i) | B, PT1, PT2 | Interview | |
| Treatment satisfaction | Adapted Satisfaction with Treatment Form | PT1, PT2 | Self-report |
| Blinding questionnaire | Treatment Blinding Questionnaire | PT1 | Self-report |
| Specimen collection | Urine toxicology screen | B, W, PT1, PT2 | Laboratory |
| Blood draw | B | Laboratory | |
| DNA collection | B | Laboratory |
DSM-V, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; EEG, electroencephalography; PTSD, post-traumatic stress disorder; SUD, substance use disorder.